Shikha Jain

Dr. Shikha Jain

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2020 in Journal of Medical Internet Research
Verified
Journal Article
Open access
Kimberly Deanne AcquavivaKimberly Deanne Acquaviva
Kimberly Deanne Acquaviva
JMJosh Mugele
Josh Mugele
NANatasha Abadilla
Natasha Abadilla
TATyler Adamson
Tyler Adamson
SBSamantha L Bernstein
Samantha L Bernstein
ATAvery M Trudell
Avery M Trudell
Background: The traditional model of promotion and tenure in the health professions relies heavily on formal scholarship through teaching, research, and service. Institutions consider how much weight to give activities in each of these areas and determine a threshold for advancement. With the emergence of social media, scholars can engage wider audiences in creative ways and have a broader impact. Conventional metrics like the h-index do not account for social media impact. Social media engagement is poorly represented in most curricula vitae (CV) and therefore is undervalued in promotion and tenure reviews. Objective: The objective was to develop crowdsourced guidelines for documenting social media scholarship. These guidelines aimed to provide a structure for documenting a scholar’s general impact on social media, as well as methods of documenting individual social media contributions exemplifying innovation, education, mentorship, advocacy, and dissemination. Methods: To create unifying guidelines, we created a crowdsourced process that capitalized on the strengths of social media and generated a case example of successful use of the medium for academic collaboration. The primary author created a draft of the guidelines and then sought input from users on Twitter via a publicly accessible Google Document. There was no limitation on who could provide input and the work was done in a democratic, collaborative fashion. Contributors edited the draft over a period of 1 week (September 12-18, 2020). The primary and secondary authors then revised the draft to make it more concise. The guidelines and manuscript were then distributed to the contributors for edits and adopted by the group. All contributors were given the opportunity to serve as coauthors on the publication and were told upfront that authorship would depend on whether they were able to document the ways in which they met the 4 International Committee of Medical Journal Editors authorship criteria. Results: We developed 2 sets of guidelines: Guidelines for Listing All Social Media Scholarship Under Public Scholarship (in Research/Scholarship Section of CV) and Guidelines for Listing Social Media Scholarship Under Research, Teaching, and Service Sections of CV. Institutions can choose which set fits their existing CV format. Conclusions: With more uniformity, scholars can better represent the full scope and impact of their work. These guidelines are not intended to dictate how individual institutions should weigh social media contributions within promotion and tenure cases. Instead, by providing an initial set of guidelines, we hope to provide scholars and their institutions with a common format and language to document social media scholarship.

8 June 2021 in Vaccines
Verified
Journal Article
Open access
PDF file
MKMeshaal Khan
Meshaal Khan
AMAjay V. Maker
Ajay V. Maker
SJShikha Jain
Shikha Jain
Immunotherapy has changed the environment of cancer treatment by providing new and efficacious therapy options for many solid and hematologic malignancies. Although not a new field of oncology, immunotherapy has quickly developed into one of the most flourishing fields in medicine. In this review article, we explore key discoveries which helped to shape our current understanding of the immune system’s role in neoplasms. Many landmark developments include the advancements in checkpoint inhibitors, monoclonal antibodies, CAR-T cells and anti-cancer vaccines. We also explore the drawbacks and efficacy of various categories of immunotherapy. Ongoing investigations within immunotherapy, such as the gut microbiome, combining checkpoint inhibitors and gene sequencing, continue to personalize treatments for cancer patients, providing exciting and endless possibilities for the future.

5 May 2022 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
VAVineet M. Arora
Vineet M. Arora
EBEve Bloomgarden
Eve Bloomgarden
SJShikha Jain
Shikha Jain
Although the spread of misinformation has escalated during the Covid-19 pandemic, the propagation of deceptive medical claims is as old as the health care profession itself. The ease with which misinformation and disinformation (inaccurate information that is purposefully misleading) are spread by means of social media, however, presents new and complex challenges. A recent survey found that 95% of people in the United States perceived misinformation to be a problem and 41% were very or extremely worried that they were personally exposed to misinformation.1

22 July 2022 in Journal of Medical Internet Research
Verified
Journal Article
Open access
RRRegina Royan
Regina Royan
TPTricia Rae Pendergrast
Tricia Rae Pendergrast
MRMarina Del Rios
Marina Del Rios
SRShannon M Rotolo
Shannon M Rotolo
NTN Seth Trueger
N Seth Trueger
VAVineet M Arora
Vineet M Arora
Social media is an important tool for disseminating accurate medical information and combating misinformation (ie, the spreading of false or inaccurate information) and disinformation (ie, spreading misinformation with the intent to deceive). The prolific rise of inaccurate information during a global pandemic is a pressing public health concern. In response to this phenomenon, health professional amplifiers such as IMPACT (Illinois Medical Professional Action Collaborative Team) have been created as a coordinated response to enhance public communication and advocacy around the COVID-19 pandemic.

21 August 2021 in Journal of the American Pharmacists Association
Verified
Journal Article
Closed access
SRShannon M. Rotolo
Shannon M. Rotolo
SJShikha Jain
Shikha Jain
SDSerena Dhaon
Serena Dhaon
JDJack K. Dokhanchi
Jack K. Dokhanchi
EKElzbieta Kalata
Elzbieta Kalata
VAVineet M. Arora
Vineet M. Arora

1 December 2024 in JCO Clinical Cancer Informatics
Verified
Journal Article
Open access
ZHZacharie Hamilton
Zacharie Hamilton
AAAseem Aseem
Aseem Aseem
Zhengjia ChenZhengjia Chen
Zhengjia Chen
NNNoor Naffakh
Noor Naffakh
Natalie ReizineNatalie Reizine
Natalie Reizine
RNRyan H. Nguyen
Ryan H. Nguyen
PURPOSE: Precision oncology in non–small cell lung cancer (NSCLC) relies on biomarker testing for clinical decision making. Despite its importance, challenges like the lack of genomic oncology training, nonstandardized biomarker reporting, and a rapidly evolving treatment landscape hinder its practice. Generative artificial intelligence (AI), such as ChatGPT, offers promise for enhancing clinical decision support. Effective performance metrics are crucial to evaluate these models' accuracy and their propensity for producing incorrect or hallucinated information. We assessed various ChatGPT versions' ability to generate accurate next-generation sequencing reports and treatment recommendations for NSCLC, using a novel Generative AI Performance Score (G-PS), which considers accuracy, relevancy, and hallucinations. METHODS: We queried ChatGPT versions for first-line NSCLC treatment recommendations with an Food and Drug Administration–approved targeted therapy, using a zero-shot prompt approach for eight oncogenes. Responses were assessed against National Comprehensive Cancer Network (NCCN) guidelines for accuracy, relevance, and hallucinations, with G-PS calculating scores from –1 (all hallucinations) to 1 (fully NCCN-compliant recommendations). G-PS was designed as a composite measure with a base score for correct recommendations (weighted for preferred treatments) and a penalty for hallucinations. RESULTS: Analyzing 160 responses, generative pre-trained transformer (GPT)-4 outperformed GPT-3.5, showing higher base score (90% v 60%; P < .01) and fewer hallucinations (34% v 53%; P < .01). GPT-4's overall G-PS was significantly higher (0.34 v –0.15; P < .01), indicating superior performance. CONCLUSION: This study highlights the rapid improvement of generative AI in matching treatment recommendations with biomarkers in precision oncology. Although the rate of hallucinations improved in the GPT-4 model, future generative AI use in clinical care requires high levels of accuracy with minimal to no room for hallucinations. The GP-S represents a novel metric quantifying generative AI utility in health care compared with national guidelines, with potential adaptation beyond precision oncology.